Published in Arch Iran Med on March 01, 2010
The gastro-esophageal malignancies in Northern Iran research project: impact on the health research and health care systems in Iran. Arch Iran Med (2013) 2.01
Hepatitis A virus infection: Is it an important hazard to public health?: hazards of HAV for public health. Hepat Mon (2011) 1.16
Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran. Hepat Mon (2016) 1.14
Seroprevalence of hepatitis A virus among Iranian soldiers. Gastroenterol Hepatol Bed Bench (2016) 0.99
Age-specific seroprevalence of anti-hepatitis a antibody among 1-30 years old population of savadkuh, mazandaran, iran with literature review. Hepat Mon (2012) 0.98
Prevention of hepatitis a virus infection, need to vaccinate or not? Int J Prev Med (2013) 0.95
Hepatitis a virus seropositivity in nurses and paramedical personnel at a university hospital in north iran. Iran Red Crescent Med J (2013) 0.91
Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran. J Res Med Sci (2014) 0.80
Seroprevalence of Hepatitis A and E Virus Infections Among Healthy Population in Shiraz, Southern Iran. Jundishapur J Microbiol (2015) 0.80
High Prevalence of Symptomatic Hepatitis A Infection in Rural Area of Chaharmahal VA Bakhtiari Province, Iran. J Clin Diagn Res (2015) 0.78
Hepatitis A seropositivity among newly admitted medical students of Isfahan, Kermanshah, and Hamedan: A seroprevalence study. J Res Med Sci (2014) 0.78
Hepatitis A Is a Health Hazard for Iranian Pilgrims Who Go to Holly Karbala: A Preliminary Report. Hepat Mon (2016) 0.75
Comparison of the Prevalence and Risk Factors of Hepatitis A in 10 to 18-Year-Old Adolescents of Sixteen Iranian Provinces: The CASPIAN-III Study. Hepat Mon (2016) 0.75
Hepatitis a virus: is vaccination necessary in middle East? Middle East J Dig Dis (2013) 0.75
Prevalence of hepatitis A across various countries in the Middle East, African and Eastern European countries. Caspian J Intern Med (2016) 0.75
Seroprevalence of Hepatitis A among Students Enrolled in Tehran University of Medical Sciences during 2011. Middle East J Dig Dis (2013) 0.75
Vaccination Against Hepatitis A for Hemophilic Patients: Is It Necessary? Hepat Mon (2016) 0.75
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ (2009) 5.79
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. Am J Gastroenterol (2007) 3.63
Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev (2005) 2.88
The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med (2009) 2.67
Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests. Eur J Gastroenterol Hepatol (2006) 2.63
Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer (2003) 2.53
Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis (2010) 2.32
Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica (2009) 2.20
Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med (2007) 2.12
Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol (2009) 2.10
Opium use and risk of mortality from digestive diseases: a prospective cohort study. Am J Gastroenterol (2013) 2.07
Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50,000 adults in Iran. BMJ (2012) 2.07
The gastro-esophageal malignancies in Northern Iran research project: impact on the health research and health care systems in Iran. Arch Iran Med (2013) 2.01
Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells. Stem Cell Rev (2010) 1.98
Esophageal cancer in Northeastern Iran: a review. Arch Iran Med (2007) 1.95
Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomarkers Prev (2004) 1.95
Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J Hypertens (2013) 1.86
Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008. Arch Iran Med (2012) 1.84
Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol (2009) 1.77
Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health (2006) 1.75
Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran. Gut (2010) 1.71
Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion (2009) 1.70
High prevalence of coeliac disease in apparently healthy Iranian blood donors. Eur J Gastroenterol Hepatol (2003) 1.69
Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Am J Clin Nutr (2014) 1.66
Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. Cancer Detect Prev (2006) 1.65
Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis. Liver Int (2013) 1.64
Healthy ranges of serum alanine aminotransferase levels in Iranian blood donors. World J Gastroenterol (2003) 1.63
Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998-2001. Arch Iran Med (2009) 1.59
Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World J Gastroenterol (2008) 1.59
Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. Arch Iran Med (2007) 1.58
High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. Anticancer Res (2005) 1.57
Prevalence of celiac disease among patients with Behcet's disease in Iran. Dig Dis Sci (2008) 1.54
Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry. Cancer Lett (2005) 1.53
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Coeliac disease in autoimmune liver disease: a cross-sectional study and a systematic review. Dig Liver Dis (2010) 1.49
Brain-derived neurotrophic factor predicts physical health in untreated patients with hepatitis C. Biol Psychiatry (2011) 1.49
Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect). Pediatr Hematol Oncol (2009) 1.48
Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2008) 1.47
Outcome of colonoscopy in elderly African-American patients. Dig Dis Sci (2009) 1.47
Probucol in the treatment of nonalcoholic steatohepatitis: an open-labeled study. J Clin Gastroenterol (2003) 1.47
Verbal autopsy: reliability and validity estimates for causes of death in the Golestan Cohort Study in Iran. PLoS One (2010) 1.47
Ecologic study of serum selenium and upper gastrointestinal cancers in Iran. World J Gastroenterol (2004) 1.47
Estimating blood transfusion requirements in preparation for a major earthquake: the Tehran, Iran study. Prehosp Disaster Med (2010) 1.45
Surface area: a better predictor of disease severity than the height and volume of the barium column in patients with primary achalasia. Eur J Gastroenterol Hepatol (2006) 1.45
Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease. Am J Gastroenterol (2006) 1.41
Topography of gastritis and its severity in 864 first degree relatives of gastric cancer patients. Arch Iran Med (2010) 1.41
Distinct high-profile methylated genes in colorectal cancer. PLoS One (2009) 1.41
Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol (2007) 1.39
Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J Med Virol (2004) 1.38
A survey of the current status of web-based databases indexing Iranian journals. Arch Iran Med (2009) 1.35
Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans. Clin Cancer Res (2009) 1.35
Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer. World J Gastroenterol (2006) 1.30
Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. J Gastroenterol Hepatol (2005) 1.30
Epidemiologic characteristics of 500 patients with inflammatory bowel disease in Iran studied from 2004 through 2007. Arch Iran Med (2009) 1.28
Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran - a review. Eur J Cancer (2009) 1.27
Epidemiology of gastroesophageal reflux symptoms in Tehran, Iran: a population-based telephone survey. Arch Iran Med (2007) 1.27
Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study. Mol Cancer (2008) 1.27
The upper normal limit of serum alanine aminotransferase in Golestan Province, northeast Iran. Arch Iran Med (2008) 1.25